Published in Kidney Int on September 01, 2000
Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell (2013) 2.49
Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol (2005) 2.38
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest (2004) 1.82
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77
Macrophages and immunologic inflammation of the kidney. Semin Nephrol (2010) 1.71
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken) (2011) 1.54
Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum (2012) 1.48
17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr(-/-) mice. Atherosclerosis (2013) 1.40
Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol (2008) 1.19
Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol (2007) 0.98
Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J Biol Chem (2011) 0.95
Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases. J Biomed Biotechnol (2012) 0.95
The kidney biopsy in lupus nephritis: is it still relevant? Rheum Dis Clin North Am (2014) 0.89
CD19+CD5+ B cells in primary IgA nephropathy. J Am Soc Nephrol (2008) 0.89
Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults. Arthritis Care Res (Hoboken) (2016) 0.86
Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol (2004) 0.83
ISN/RPS 2003 class II mesangial proliferative lupus nephritis: a comparison between cases that progressed to class III or IV and cases that did not. Rheumatol Int (2011) 0.80
Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2016) 0.80
Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices. Rheumatol Int (2015) 0.78
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities. Semin Immunol (2016) 0.78
The Holy Grail: pathological indices in lupus nephritis. Kidney Int (2000) 0.77
Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis. Arthritis Res Ther (2012) 0.77
Conference report--lupus nephritis: diagnosis, therapy, and outcomes. MedGenMed (2004) 0.76
The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis. Semin Nephrol (2015) 0.76
Clinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody: A Retrospective Study. Medicine (Baltimore) (2016) 0.75
Do we still need renal biopsy in lupus nephritis? Reumatologia (2016) 0.75
Advances in the Care of Children with Lupus Nephritis. Pediatr Res (2016) 0.75
A clinicopathological study on lupus nephritis; experience of 34 cases from Bangladesh. J Nephropharmacol (2015) 0.75
Overview of pathophysiology and treatment of human lupus nephritis. Curr Opin Rheumatol (2016) 0.75
A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system. J Lab Physicians (2017) 0.75
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol (2017) 0.75
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord (1999) 2.98
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet (2000) 2.97
Pefloxacin as first-line treatment in nephrotic syndrome. Lancet (1992) 2.58
Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int (2006) 2.07
Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant (2010) 1.92
Mesangial IgA deposits in two patients with AIDS-related complex. Nephron (1990) 1.92
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant (2010) 1.86
Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett (2000) 1.82
Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology (2000) 1.81
The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant (1999) 1.72
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant (2009) 1.67
Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature. Clin Nephrol (1992) 1.66
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant (2011) 1.66
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant (2009) 1.65
Minimal change nephrotic syndrome revealing solid tumors. Nephron (1992) 1.58
Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int (2001) 1.57
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant (2011) 1.57
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation. Am J Transplant (2009) 1.55
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant (2009) 1.52
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant (2007) 1.49
Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med (1993) 1.48
Granulomatous interstitial nephritis. Adv Nephrol Necker Hosp (1984) 1.43
[Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance]. Nephrologie (2002) 1.41
Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies. Q J Med (1983) 1.41
[Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients]. Nephrologie (1997) 1.41
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int (2006) 1.40
Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant (1993) 1.39
Hemodialysis access fistula creation: preoperative assessment with MR venography and comparison with conventional venography. Radiology (1998) 1.39
Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transplant (2013) 1.31
Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int (1992) 1.30
Unusual radiologic findings in the thorax after radiation therapy. Radiographics (2000) 1.28
Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol (1976) 1.28
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant (2007) 1.24
Glomerular lesions in lymphomas and leukemias. Am J Med (1986) 1.22
Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review. Clin Infect Dis (1999) 1.21
Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int (1998) 1.21
Life-threatening spontaneous psoas haematoma treated by transcatheter arterial embolization. Eur Radiol (1999) 1.19
Immunologically mediated drug-induced acute renal failure. Contrib Nephrol (1978) 1.17
Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Am J Med (1980) 1.15
Retained surgical sponge or gossypiboma of the breast. Eur J Radiol (2002) 1.13
Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients. Medicine (Baltimore) (1987) 1.10
Axial motor disturbances after hypoxic lesions of the globus pallidus. Mov Disord (1993) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int (2006) 1.06
Nephropathy associated with infection by human immunodeficiency virus: a report on 11 cases including 6 treated with zidovudine. Nephron (1992) 1.04
Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement. Clin Nephrol (1985) 1.04
Acute oxalate nephropathy: A new etiology for acute renal failure following nonrenal solid organ transplantation. Am J Transplant (2006) 1.04
Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol (1985) 1.04
Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res (1997) 1.04
Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol (2000) 1.02
Spontaneous hemomediastinum complicating steroid-induced mediastinal lipomatosis. Chest (2001) 1.00
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant (2008) 0.99
The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron (1976) 0.98
Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology. Am J Transplant (2013) 0.98
Rapidly progressive ('crescentic') glomerulonephritis and monoclonal gammapathies. Nephron (1984) 0.98
Thigh cellulitis caused by toothpick ingestion. Intensive Care Med (2003) 0.97
Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol (1991) 0.97
Antitubular basement membrane antibodies in rapidly progressive poststreptococcal glomerulonephritis: report of a case. Clin Immunol Immunopathol (1974) 0.97
Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int (2000) 0.96
HgC12 induces T and B cells to proliferate and differentiate in BN rats. Clin Exp Immunol (1988) 0.96
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol (2008) 0.96
Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int (2001) 0.95
Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child (1991) 0.95
Sequential immunological targeting of chronic experimental arterial allograft. Transplantation (1995) 0.94
Hantavirus-related acute interstitial nephritis in western Europe. Expansion of a world-wide zoonosis. Q J Med (1989) 0.94
Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol (1994) 0.94
[Sclerosing peritonitis. A series of 10 cases and review of the literature]. Gastroenterol Clin Biol (1995) 0.93
Renal lesions in multiple myeloma: their relationship to associated protein abnormalities. Am J Kidney Dis (1983) 0.93
Letter: Remission in renal amyloidosis. Ann Intern Med (1975) 0.93
[Intralobar sequestration of the lung in an adult (type 1 of pryce). Treatment by coil embolization]. J Radiol (2000) 0.91
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum Gene Ther (2000) 0.91
Simultaneous IgA nephropathy and Wegener's granulomatosis--overlap or coincidence (the role of renal biopsy). Nephrol Dial Transplant (1999) 0.91
Abnormalities of renin-containing cells in human glomerular and vascular renal diseases. Kidney Int (1983) 0.89
Renal lesions in the hypertensive syndromes of pregnancy: immunomorphological and ultrastructural studies in 114 cases. Clin Nephrol (1980) 0.88
[Extracorporeal radiation of the blood by ultraviolet rays]. Nouv Rev Fr Hematol (1969) 0.88
Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients. Eur J Immunol (1995) 0.88
Experimental gold-induced autoimmunity. Nephrol Dial Transplant (1991) 0.88
Ototoxicity of erythromycin in patients with renal insufficiency. N Engl J Med (1979) 0.88
Genetic heterogeneity of familial hyperkalaemic hypertension. J Hypertens (2001) 0.88
Functional evaluation of normal and ischemic kidney by means of gadolinium-DOTA enhanced TurboFLASH MR imaging: a preliminary comparison with 99Tc-MAG3 dynamic scintigraphy. Magn Reson Imaging (1994) 0.87
[Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (author's transl)]. Nephrologie (1980) 0.86
The course of lupus nephritis: contribution of serial renal biopsies. Adv Nephrol Necker Hosp (1976) 0.86
Late presentation of solitary contralateral adrenal metastasis of renal cell carcinoma. Eur Radiol (1997) 0.86
Changes in erythromycin pharmacokinetics induced by renal failure. Clin Nephrol (1987) 0.86
Failing arteriovenous hemodialysis fistulas: assessment with magnetic resonance angiography. Invest Radiol (1999) 0.85
Acute renal and hepatic failure: do not miss pericardial tamponade! Nephrol Dial Transplant (1999) 0.85
Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol (1994) 0.84
Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents. AJR Am J Roentgenol (1999) 0.84